CORRELATION BETWEEN MICROALBUMINURIA AND SEVERITY OF CORONARY ARTERY STENOSIS IN PATIENTS WITH TYPE II DIABETES MELLITUS

Document Type : Original Article

Authors

Cardiology Department, Al-Azhar Faculty of Medicine, New Damietta

Abstract

Background: Cardiovascular disease is the major cause of death in patients with diabetes mellitus. Microalbuminuria (MAU) is defined as persistent subclinical elevation of urinary albumin excretion rate (UAER), which is insufficient to be demonstrated by reagent strips.
Objective: to determine the correlation between microalbuminuria and the severity of coronary artery stenosis assessed by Gensini score in patients with type II diabetes mellitus
Patients and methods: This study included sixty-one patients with type II diabetes mellitus and suspected coronary artery disease that underwent elective coronary angiography in Al-Azhar University Hospital, New Damietta, during the period between October 2013 and October 2014. Patients were classified into two groups based on the level of urinary albumin: creatinine ratio (UACR): Group I included 32 patients (52.5 %) with microalbuminuria (UACR level ranging from 30 to less than 300 mg/g), and Group II included 29 patients (47.5 %) with normoalbuminuria (UACR level less than 30 mg/g). All patients were subjected to full history taking,clinical assessment, standard 12-lead surface electrocardiogram (ECG), echocardiography,laboratory investigations, andcoronary angiography.
Results: This study showed that UACR and Gensini score increased with age. There was a significant positive correlation between UACR and total cholesterol, triglycerides, LDL-C and glycosylated hemoglobin (HgbA1c), while there was a significant negative correlation with HDL-C and smoking. There was a significant positive correlation between Gensini score and urinary albumin level. The Gensini score was correlated with LDL- C and no correlation with total cholesterol, triglycerides, HDL-C and glycosylated hemoglobin (HgbA1c) or smoking. In the present study, the number of coronary vessels affected was higher in patients with microalbuminuria than those without microalbuminuria. The severity of coronary artery disease assessed by Gensini score was significantly higher in patients with microalbuminuria than those without microalbuminuria, and there was a correlation between UACR and Gensini score as a measurement of severity of coronary artery stenosis.
Conclusion: In patients with type II DM, microalbuminuria can be used as a predictor for coronary artery disease severity.

Keywords


CORRELATION BETWEEN MICROALBUMINURIA AND SEVERITY OF CORONARY ARTERY STENOSIS IN PATIENTS WITH TYPE II DIABETES MELLITUS

 

By

 

Khaled I. Nageuib, Mohammed A. Attia, Mohammed S. Bashandy,  Hammouda Abdul-Khalik, Mohamed A. Omar

and Khaled A. Aboualmagd

 

Cardiology Department, Al-Azhar Faculty of Medicine, New Damietta

 

ABSTRACT

Background: Cardiovascular disease is the major cause of death in patients with diabetes mellitus. Microalbuminuria (MAU) is defined as persistent subclinical elevation of urinary albumin excretion rate (UAER), which is insufficient to be demonstrated by reagent strips.

Objective: to determine the correlation between microalbuminuria and the severity of coronary artery stenosis assessed by Gensini score in patients with type II diabetes mellitus

Patients and methods: This study included sixty-one patients with type II diabetes mellitus and suspected coronary artery disease that underwent elective coronary angiography in Al-Azhar University Hospital, New Damietta, during the period between October 2013 and October 2014. Patients were classified into two groups based on the level of urinary albumin: creatinine ratio (UACR): Group I included 32 patients (52.5 %) with microalbuminuria (UACR level ranging from 30 to less than 300 mg/g), and Group II included 29 patients (47.5 %) with normoalbuminuria (UACR level less than 30 mg/g). All patients were subjected to full history taking,clinical assessment, standard 12-lead surface electrocardiogram (ECG), echocardiography,laboratory investigations, andcoronary angiography.

Results: This study showed that UACR and Gensini score increased with age. There was a significant positive correlation between UACR and total cholesterol, triglycerides, LDL-C and glycosylated hemoglobin (HgbA1c), while there was a significant negative correlation with HDL-C and smoking. There was a significant positive correlation between Gensini score and urinary albumin level. The Gensini score was correlated with LDL- C and no correlation with total cholesterol, triglycerides, HDL-C and glycosylated hemoglobin (HgbA1c) or smoking. In the present study, the number of coronary vessels affected was higher in patients with microalbuminuria than those without microalbuminuria. The severity of coronary artery disease assessed by Gensini score was significantly higher in patients with microalbuminuria than those without microalbuminuria, and there was a correlation between UACR and Gensini score as a measurement of severity of coronary artery stenosis.

Conclusion: In patients with type II DM, microalbuminuria can be used as a predictor for coronary artery disease severity.

Keywords: Gensini Score, Diabetes Mellitus, microalbuminuria; coronary artery stenosis.

  

 

INTRODUCTION

     Diabetes mellitus (DM) is a chronic metabolic disease, wide spread through the world with huge social, health and economic consequences. It estimates approximately 360 million people had DM in 2011and more than 95% of them had type II DM. This number will be increased to 552 million by 2030 and it is thought that about half of those will be unaware of their diagnosis (Lars et al., 2013).

     Cardiovascular disease is the major cause of death in those patients. Many of diabetic patients with coronary artery disease (CAD) do not have any other classic risk factor for coronary artery disease and half of them have normal lipid profile (Pahor et al., 1999).

     Microalbuminuria (MAU) is defined as persistent subclinical elevation of urinary albumin excretion rate (UAER). It is considered a marker of endothelial dysfunction and vascular damage which could be a predictor of coronary artery atherosclerosis (Stehouwer et al., 2004).

     The urinary albumin: creatinine ratio (UACR) has been shown to be convenient, and efficient in screening patients for microalbuminuria when compared with 24-hour collections and has been suggested for diabetic and hypertensive patients (Afkhami et al., 2007).

     Description of a coronary artery disease by Gensini scoring system was intended to take into account the geometrically increasing severity of lesions by diameter reduction, cumulative effect of multiple lesions, lesion location and influence of collaterals (Gensini, 1975).

      The aim of this study was to determine the correlation between micro-albumi-nuria and the severity of coronary artery stenosis assessed by Gensini score in patients with type II diabetes mellitus.

PATIENTS AND METHODS

      This study was a cross-sectional study included sixty-one patients with type II diabetes mellitus and suspected coronary artery disease that underwent elective coronary angiography in Al-Azhar University Hospital, New Damietta, during the period between October 2013 and October 2014. Twenty-seven patients of the study population were males (44.3%) and thirty-four were females (55.7%).

Inclusion criteria: This study included patients with type II DM with suspected CAD candidate for elective coronary angiography

Exclusion criteria: Patients with macroalbuminuria, renal impairment, acute myocardial infarction (MI), or congestive heart failure (CHF) were excluded from the study. Also, patients already receiving angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) were excluded.

    Patients were classified into two groups based on the level of UACR: Group I included 32 patients (52.5 %) with microalbuminuria (UACR level ranging from 30 to less than 300 mg/g); and Group II included 29 patients (47.5 %) with normoalbuminuria (UACR level less than 30 mg/g).

     All patients were subjected to full history taking, clinical assessment including general and local examinations, and laboratory investigations including complete blood count (CBC), glycosylated hemoglobin (HgbA1c), serum creatinine (Cr.), liver function tests (liver enzymes, serum albumin, and bilirubin), lipid profile, and urinary albumin to creatinine ratio, standard 12-lead surface electrocardiogram (ECG), echocardiography, and coronary angiography.

Statistical analysis of data: The collected data were coded, tabulated and statistically analyzed using statistical package for social sciences (SPSS) version 16, running on IBM-compatible computer. Quantitative data were expressed in arithmetic mean ± standard deviation (SD), while qualitative data were expressed in relative frequency and percentage. Comparison between groups was done by unpaired (t) test for normally distributed and Mann Whitney (U) test for non-normally distributed quantitative data of two independent samples; and Chi-square test (χ2) for comparison of qualitative data. Receiver operating characteristics (ROC) curve was used to determine the sensitivity and specificity of different cut-off points and Pearson’s correlation coefficient (r) was used to detect association between different variables. The level of significance was taken at p ≤ 0.05, for interpretation of results.

RESULTS

     There was a significant increase of age in group I when compared to group II (58.78±6.36 vs 54.38 ± 5.97 respectively). In addition, there were significant increases of hypertension, dyslipidemia, and hyperuricemia in group I when compared to group II (78.1%, 46.9% and 15.6% vs 37.9%, 10.3% and 0.0% respectively), while smoking significantly higher in group II when compared to group I (31.0% vs 3.1% respectively).  Furthermore, there were significant increases of HbA1c, triglycerides (TG), cholesterol and LDL in group I when compared to group II (8.47±1.20, 237.01±69.42, 247.58±40.62 and 140.68±27.50 vs 7.14±1.13, 123.87± 71.63, 147.20±53.80 and 58.36±37.95 respectively), while there was significant decrease of HDL in group II when compared to group I (34.12±5.29 vs 53.20±10.01 respectively). Finally, there were significant increases of urinary albumin, UACR, Gensini score and number of affected vessels in group II when compared to group I (52.77±29.38, 64.76±17.94, 59.89±42.24 and 2.16±1.14 vs 19.18±10.99, 16.12± 7.11, 27.78±32.52 and 1.17±1.23 respectively - Table 1).

     As regard correlation between UACR and other variables, there were significant positive (proportional) correlations between UACR from one side and each of age, number of affected vessels, TG, cholesterol, LDL and HbA1c from the other side, while there were significant negative (inverse) correlations between UACR from one side and each of HDL and smoking. In addition, there were positive significant correlations between Genisini score from one side and each of age, LDL and urinary albumin from the other side (table 2). Finally, based on ROC curve, 31.7 mg/dl was the best cut off point for urinary albumin level that differentiates Gensini score above and below 70. Area under the curve was 0.89; sensitivity and specificity were 89.5 % and 78.6%, respectively (Figure 1). In addition, 41.3 mg/g was the best cut-off point for microalbuminuria by UACR that differentiates Gensini score above and below 70. Area under the curve was 0.69; sensitivity and specificity were 73.7% and 64.3%, respectively (figure 2).

 

 

Table (1): Comparison between group I and II as regard to different variables of the study population.

Groups

Variables

Group I (n=32)

(microalbuminuria)

Group II(n=29)

(normoalbuminuria)

P value

Age (years)

58.78±6.36

54.38±5.97

0.007*

Male gender

12(37.5%)

15(51.7%)

0.19

 

Risk factors

Hypertension

25(78.1%)

11(37.9%)

0.002*

Dyslipidemia

15(46.9%)

3(10.3%)

0.002*

Smoking

1 (3.1%)

9(31.0%)

0.004*

Hyperuricemia

5(15.6%)

0(0.0%)

0.034*

Rheumatoid arthritis

1(3.1%)

0(0.0%)

0.52

Systolic blood pressure (mmHg)

138.75±8.23

134.83±8.61

0.07

Diastolic blood pressure (mmHg)

83.75±7.41

83.79±7.15

0.9

 

 

 

 

Investigations

HbA1c (%)

8.47±1.20

7.14±1.13

<0.001*

TG (mg/dl)

237.01±69.42

123.87±71.63

<0.001*

Cholesterol (mg/dl)

247.58±40.62

147.20±53.80

<0.001*

LDL (mg/dl)

140.68±27.50

58.36±37.95

<0.001*

HDL (mg/dl)

34.12±5.29

53.20±10.01

<0.001*

Serum creatinine (mg/dl)

0.98±0.19

0.96±0.22

0.51

Urinary albumin (mg/dl)

52.77±29.38

19.18±10.99

<0.001*

UACR (mg/g)

64.76±17.94

16.12±7.11

<0.001*

Gensini score

59.89±42.24

27.78±32.52

0.002*

Number of affected vessels

2.16±1.14

1.17±1.23

0.002*

* Significant.

Table (2): Correlation between UACR and Gensini score with other variables.

                                         Correlation

Variables

UACR

Gensini score

r

P

R

p

Age (Years)

0.32

0.01*

0.41

0.001*

Number of affected vessels

0.3

0.02*

0.85

<0.001*

TG (mg/dl)

0.62

<0.001*

0.22

0.88

Cholesterol (mg/dl)

0.7

<0.001*

0.18

0.17

LDL (mg/dl)

0.81

<0.001*

0.30

0.03*

HDL (mg/dl)

-0.76

<0.001*

-0.19

0.13

HbA1c (%)

0.62

<0.001*

0.04

0.7

Smoking

-0.37

0.004*

-0.08

0.5

Systolic blood pressure (mmHg)

0.25

0.051

0.25

0.057

Diastolic blood pressure (mmHg)

0.017

0.90

-0.11

0.41

Urinary albumin (mg/dl)

0.66

<0.001

0.7

<0.001*

Serum creatinine (mg/dl)

0.17

0.19

0.16

0.2

* Significant.

   

Figure (1): ROC curve of urinary albumin level that differentiates patients with Gensini score above and below seventy.

Figure (2): ROC curve of microalbuminuria level that differentiates patients with Gensini score above and below seventy

 

 

DISCUSSION

Microalbuminuria is a significant risk factor for cardiovascular mortality in type I and type II diabetes mellitus, as well as in non-diabetic population. It reflects systemic vascular damage, closely associated with microangiopathy and increased risk of coronary heart disease (Klasen et al., 2004).

Cardiovascular diseases are the leading cause of death in patients with type II diabetes mellitus. Similarly, in patients with established cardiovascular diseases diabetes caries a greater risk of worse outcomes and increases the risk of morbidity and mortality especially when associated complications such as nephropathy, retinopathy and possibly neuropathy are present (Barkoudah et al., 2012).

The age of the patients with micro-albuminuria was significantly higher than those with normoalbuminuria which was in agreement with those results reported by Hashim et al. (2006), Hoseini & Rasouli (2009), El Sherif et al. (2011), and  Parsa et al. (2013) who found that microalbuminuria increasing with age. While in studies by Parvizi et al. (2005) and Sukhija et al. (2006) there was no correlation between MAU and age due to small sample size. In the present study, there was no difference between the 2 groups as regards gender distribution, and this was in agreement with results by Parvizi et al. (2005) and Sukhija et al. (2006) who reported that there was no difference between males and females as regards microalbuminuria. However, Hashim et al. (2006), Hoseini & Rasouli (2009), Parsa et al. (2013) and Sadaka et al. (2013) found that microalbuminuria was higher inmales with no statistically significant difference.

The present study showed that there was a significant correlation between UACR and number of vessels affected. This result was in agreement with those reported by Parvizi et al. (2005), Hoseini & Rasouli (2009) and Sadaka et al. (2013) who found that MAU was correlated with number of vessels affected.

In the present study serum choles-terol, triglycerides and LDL-C levels were higher in patient with MAU than those without MAU while HDL-C was lower, and there was a significant correlation between MAU and lipid profile, and these results were in agreement with those reported by Johnsen et al. (1999), Sigdel et al. (2008) and Aziz et al. (2014) who concluded that TC, TG, and LDL-C levels were higher in MAU group. While, Sukhija et al. (2006), Hoseini & Rasouli (2009) and Parsa et al. (2013) showed that there was no correlation between MAU and lipid profile, it could be due to race, medications and geographic or nutritional factors.

In the present study, the serum glycosylated hemoglobin (HgbA1c) was higher in patients with MAU than those without MAU and there was a significant correlation between MAU and HgbA1c. This result was in agreement with those reported by Sukhija et al. (2006) and El Sherif et al. (2011) who concluded that MAU was correlated with HgbA1c, while Jun et al. (2010) showed that MAU was not correlated with HgbA1c.

In the present study, there was a negative correlation between microal-buminuria and smoking. This result was not in agreement with those reported by Parvizi et al. (2005), Hoseini et al. (2009), Parsa et al. (2013) and He et al. (2014) who concluded that there was nocorrelation between microalbuminuria and smoking, it could be due to sample size withfemale predominance.

This study showed that there was a significant positive correlationbetween Gensini score and age, and this was in agreement with thosereported by El Sherif et al. (2011), Kim et al. (2013), Parsa et al. (2013), He et al. (2014) and Hong et al. (2014) who found a significant positivecorrelation between Gensini score and age.

In the present study, there was a significant correlation between Gensini score and urinary albumin level, and there is no data available to compare with them. Also, Gensini score was significantly correlated with LDL-C level, while there was no correlation between Gensini score and triglycerides, cholesterol, HDL-C, HgbA1c or smoking. These results were not in agreement with those reported by El Sherif et al. (2011) and Hong et al. (2014) who concluded that there was a correlation between Gensini score and HgbA1c. Kim et al. (2013) found that there were correlations between Gensini score and triglycerides, HDL-C and LDL-C. Sukhija et al. (2006) and Parsa et al. (2013) found that there was no correlation between Gensini score and triglycerides, cholesterol, HDL-C, LDL-C or smoking. These differences could be due to survey period, sample size and medications.

In the present study, Gensini score, as a measurement of severity of coronary artery disease, was significantly higher in patients with microalbuminuria than those without microalbuminuria. This result was in agreement with those reported by El Sherif et al. (2011) and Parsa et al. (2013) who concluded that the Gensini score of patients with MAU is signifi-cantly higher than patients without MAU. Also, our study showed that there was a significant positive correlation between microalbuminuria and Gensini score. This result was in agreement with those reported by El Sherif et al. (2011) and Parsa et al. (2013) who concluded that the Gensini score and MAU were correlated significantly. Other studies showed that there was a correlation betweenmicroalbuminuria and severity of coronary artery disease as thosereported by Sadaka et al. (2013) who found that patientswith MAU had more extensive and complex angiographic CADcompared to those without MAU with a direct relationship between MAUand extension of atherosclerotic coronary lesions.Also, Hoseini and Rasouli (2009) concluded that MAU was more prevalent in CAD-positive patients than in CAD-negative patients, and MAU exhibited a significant correlation with the severity of CAD. In addition, the patients with MAU had a much greater atherosclerotic burden in the form of multi-vessel disease than those without MAU. Similar results were presented by Sukhija et al. (2006) who studied 4 groups patients with DM and MAU, patients with DM and without MAU, patients with MAU and without DM and patients without DM and MAU and concluded that there was a graded increase in extent of angiographic CAD from group of patients with DM and MAU to group of patients without DM and MAU. Thus, patients with MAU had more severe angiographic CAD than those without MAU. In another study performed by Parvizi et al. (2005), the results showed that the UACR in patients with CAD was higher than that of the control group patients with normal coronary arteries with a significant correlation between the extend of atherosclerotic lesions and UACR.

CONCLUSION

     In patients with type II DM, microalbuminuria can be used as a predictor for coronary artery disease severity.

REFERENCES

1. Afkhami A, Modrresi M and Amirchaghmaghi I (2007): Prevalence of microalbuminuria and its risk factors in type 2 diabetic patients. Indian Journal of Nephrology, 18(3): 112-117.

2. Aziz K (2014): Association of Microalbumi-nuria with Ischemic Heart Disease, Dyslipidemia, and Obesity among Diabetic Patients.Bioenergetics, 3: 2: 1-10.

3. Barkoudah E, Skali H, Uno H, Scott D, Solomon A and Marc P (2012): Mortality Rates in Trials of Subjects with Type II Diabetes. J Am Heart Assoc., 1: 8-15.

4. El Sherif A, Khaled M, Ibrahim A and Elhattab M (2011): Association of Glyco-sylated Haemoglobin Level and Microalbumi-nuria with the Severity of Coronary Artery Disease.Journal of American Science, 7(12): 1097-1106.

5. Gensini G (1975): The coronary artery disease scoring and retrieval system of Gensini (Card scores) Coronary arteriography, pbl. Futura Publishing Company, Inc, Mount Kisco, NY; pp. 271-274.

6. Hashim R, Nisar S, Rehman K and Naqi N (2006): Microalbuminuria: association with ischemic heart diseases in non-diabetics.J Ayub Med Coll Abbottabad, 18(1): 1-4.

7. He L, Zhao J, Han J, Shen S and Chen X (2014): Correlation between serum free fatty acids levels and Gensini score in elderly patients with coronary heart disease. Journal of Geriatric Cardiology, 11: 57−62.

8. Hong L, Li X, Luo S, Guo Y, Zhu C, Qing P, Wu N and Li J (2014): Association of Fibrinogen with Severity of Stable Coronary Artery Disease in Patients with Type 2 Diabetic Mellitus.Dis. Markers, 485687: 1-8.

9. Hoseini V and Rasouli M (2009): Micro-albuminuria correlates with the prevalence and severity of coronary artery disease in non-diabetic patients.Cardiol J., 16 (2): 142–145.

10. Johnsen K, Rasmussen B, Strandgaard S, Schroll M and Jensen J (1999): Urinary albumin excretion an independent predictor of ischemic heart disease.Arterioscler Thromb Vas Biol., 19(8): 1992-1997.

11. Kim Y, Hwang I, Lee K, Lee D, Lee S, Shin M, Rhee H, Yang B, Song S, Seong E and Kwak I (2013): Decreased Renal Function Is an Independent Predictor of Severity of Coronary Artery Disease: An Application of Gensini Score.J Korean Med Sci., 28: 1615-1621.

12. Klasen I, Reichert L, Angelino C and Wetzels J (2004): Quantitative determination of low and high molecular weight proteins in human urine: influence of temperature and storage time.Clinical Chemistry, 45: 430-432.

13. Lars R, Peter J, Stefan D, Christian B, Francesco C, Nicolas D, Christi D, Javier E, Hans P, Heikki H, Michel M, Nikolaus M, Linda M, Jan O, Carlo P, Petar S, Miguel S, Marja R, Michal T, Jaakko T, Paul V and Jose L (2013): Pre-diabetes, and cardio-vascular diseases developed in collaboration with the EASD. European Heart Journal, 10: 1093-1123.

14. Pahor M, Elam M, Garrison R, Kritchevsky S and Applegate W (1999): Emerging noninvasive biochemical measures to predict cardiovascular risk. Archives of Internal Medicine, 159(3): 237-245.

15. Parsa A, Ghadirian L, Kanafi S and Farsani E (2013): Positive Correlation between Microalbuminuria and Severity of Coronary Artery Stenosis in Patients with Type 2 Diabetes Mellitus. Acta Medica Iranica., 51(4): 231-235.

16. Parvizi R, Rahbani M, Salmasi S and Safavi M (2005): Relationship between Microalbumi-nuria and Extent of Coronary Atherosclerotic Lesions.Iranian Heart Journal, 6 (1, 2): 20-25.

17. Sadaka M, Elhadedy A, Abdelhalim S and Elashmawy H (2013): Albumin to creatinine ratio as a predictor to the severity of coronary artery disease.Alexandria Journal of Medicine, 49: 323–328.

18. Sigdel M, Rajbhandari N, Basnet S, Nagila A, Basnet P and Tamrakar B (2008): Microalbuminuria among type-2 diabetes mellitus patients in Pokhara, Nepal Med Coll., 10(4): 242-245.

19. Stehouwer C, Henry R, Dekker J, Nijpels G, Heine R and Bouter L (2004): Microalbuminuria is associated with impaired brachial artery, flow-mediated vasodilation in elderly individuals without and with diabetes: Further evidence for a link between microalbuminuria and endothelial dysfunction The Hoorn Study. Kidney International, 92: 42-44.

20. Sukhija R, Aronow W, Kakar P, Garza L, Sachdeva R, Sinha A and Mehta J (2006): Relation of Microalbuminuria and Coronary Artery Disease in Patients With and Without Diabetes Mellitus.Am Journal of Card., 98:3: 279–281.


العلاقة بین الزلال الدقیق بالبول وشدة ضیق الشرایین التاجیة فی مرضى النوع الثانی من مرض السکری

خالد نجیب - محمد عادل عطیة - محمد سید بشندی - حمودة عبد الخالق

محمد الشحات عمر - خالد السید أبو المجد

 

قسم القلب والأوعیة الدمویة (کلیة طب الأزهر- دمیاط الجدیدة)

خلفیة البحث: تعتبر أمراض القلب والشرایین التاجیة من الأسباب الرئیسیة للوفاة فی مرضى  السکری، ویعرف الزلال الدقیق فى البول علی أنه الإرتفاع المستمر فی معدل إفراز زلال الألبیومین الدقیق فى  البول والذی لا یمکن تحدیده والکشف عنه بأشرطة الکواشف التقلیدیة.

الهدف من البحث: تقییم العلاقة بین الزلال الدقیق بالبول وشدة ضیق الشرایین التاجیة محددة بمقیاس جنسینی فی مرضى النوع الثانی من مرض السکری.  

مواد وطرق البحث: إشتملت هذه الدراسة على واحد وستین مریضا من النوع الثانی لمرض السکری  الذین تم عمل لهم قسطرة تشخیصیة نتیجة اشتباه فی وجود قصور بالشرایین التاجیة و تم إختیار المرضى من  المستشفیات والعیادات الخارجیة لجامعة الأزهر، فی الفترة من أکتوبر ٢٠١٣، وحتى أکتوبر ٢٠١٤ . وتم تقسیم المرضی  إلى مجموعتین  بناء علی نسبة الزلال الدقیق بالبول حیث اشتملت المجموعة الأولى على اثنین و ثلاثین مریضا (52.5 %) یعانون من وجود الزلال الدقیق بالبول (حیث معدل الألبیومین إلى الکریاتینین  فی البول یتراوح من ٣٠ إلى٣٠٠ملیجرام/جرام)، و اشتملت المجموعة الثانیة على تسعة وعشرون مریضا (47.5%) لا یعانون من وجود الزلال الدقیق بالبول (حیث معدل الألبیومین إلى الکریاتینین فی البول أقل من ٣٠ ملیجرام/جرام). وقد خضع جمیع الأشخاص لأخذ تاریخ مرضى کامل مع فحص إکلینیکى ، کما تم عمل رسم قلب کهربائی، وموجات فوق صوتیة علی القلب، وفحوصات معملیة وقسطرة تشخیصیة لشرایین القلب.

النتائج: أظهرت هذه الدراسة وجود زیادة لمعدل الألبیومین إلى الکریاتینین بالبول ومقیاس جینسینی مع تقدم العمر، کما کان هناک ارتباطاً موجباً معتبراً بین معدل الألبیومین إلى الکریاتینین  بالبول، ونسبة الکولیستیرول الکلی، والدهون الثلاثیة، والبروتینات الدهنیة منخفضة الکثافة و نسبة الهیموجلوبین السکرى بالدم، بینما کان هناک ارتباطاً سالباً معتبراً مع نسبة البروتینات الدهنیة عالیة الکثافة والتدخین .

کما کان هناک ارتباطاً موجباً معتبراً بین مقیاس جنسینی ونسبة الألبیومین بالبول وبین مقیاس جینسینی ونسبة البروتینات الدهنیة منخفضة الکثافة، بینما لم یکن هناک أی ارتباط بین مقیاس جینسینی من جهة وبین نسبة الکولیستیرول الکلی، والدهون الثلاثیة، والبروتینات الدهنیة عالیة الکثافة، ونسبة الهیموجلوبین السکری والتدخین .

کما أظهرت هذه الدراسة أن عدد الشرایین التاجیة التی بها قصور کان أعلی فی المرضی الذین  یعانون من وجود الزلال الدقیق بالبول. وقد کانت شدة قصور الشرایین التاجیة التی تم قیاسها بمقیاس جینسینی أعلى فی المرضی الذین لدیهم نسبة زلال دقیق بالبول عن المرضی الذین لا یعانون من وجود الزلال الدقیق بالبول. کما کان هناک ارتباطاً بین معدل الألبیومین إلى الکریاتینین بالبول وشدة ضیق الشرایین التاجیة محددة بمقیاس جینسینی.

الإستنتاج: فى المرضى الذین یعانون من النوع الثانی من مرض السکری  یمکن استخدام الزلال الدقیق بالبول کمؤشر علی شدة إصابة الشرایین التاجیة.

REFERENCES
1. Afkhami A, Modrresi M and Amirchaghmaghi I (2007): Prevalence of microalbuminuria and its risk factors in type 2 diabetic patients. Indian Journal of Nephrology, 18(3): 112-117.
2. Aziz K (2014): Association of Microalbumi-nuria with Ischemic Heart Disease, Dyslipidemia, and Obesity among Diabetic Patients.Bioenergetics, 3: 2: 1-10.
3. Barkoudah E, Skali H, Uno H, Scott D, Solomon A and Marc P (2012): Mortality Rates in Trials of Subjects with Type II Diabetes. J Am Heart Assoc., 1: 8-15.
4. El Sherif A, Khaled M, Ibrahim A and Elhattab M (2011): Association of Glyco-sylated Haemoglobin Level and Microalbumi-nuria with the Severity of Coronary Artery Disease.Journal of American Science, 7(12): 1097-1106.
5. Gensini G (1975): The coronary artery disease scoring and retrieval system of Gensini (Card scores) Coronary arteriography, pbl. Futura Publishing Company, Inc, Mount Kisco, NY; pp. 271-274.
6. Hashim R, Nisar S, Rehman K and Naqi N (2006): Microalbuminuria: association with ischemic heart diseases in non-diabetics.J Ayub Med Coll Abbottabad, 18(1): 1-4.
7. He L, Zhao J, Han J, Shen S and Chen X (2014): Correlation between serum free fatty acids levels and Gensini score in elderly patients with coronary heart disease. Journal of Geriatric Cardiology, 11: 57−62.
8. Hong L, Li X, Luo S, Guo Y, Zhu C, Qing P, Wu N and Li J (2014): Association of Fibrinogen with Severity of Stable Coronary Artery Disease in Patients with Type 2 Diabetic Mellitus.Dis. Markers, 485687: 1-8.
9. Hoseini V and Rasouli M (2009): Micro-albuminuria correlates with the prevalence and severity of coronary artery disease in non-diabetic patients.Cardiol J., 16 (2): 142–145.
10. Johnsen K, Rasmussen B, Strandgaard S, Schroll M and Jensen J (1999): Urinary albumin excretion an independent predictor of ischemic heart disease.Arterioscler Thromb Vas Biol., 19(8): 1992-1997.
11. Kim Y, Hwang I, Lee K, Lee D, Lee S, Shin M, Rhee H, Yang B, Song S, Seong E and Kwak I (2013): Decreased Renal Function Is an Independent Predictor of Severity of Coronary Artery Disease: An Application of Gensini Score.J Korean Med Sci., 28: 1615-1621.
12. Klasen I, Reichert L, Angelino C and Wetzels J (2004): Quantitative determination of low and high molecular weight proteins in human urine: influence of temperature and storage time.Clinical Chemistry, 45: 430-432.
13. Lars R, Peter J, Stefan D, Christian B, Francesco C, Nicolas D, Christi D, Javier E, Hans P, Heikki H, Michel M, Nikolaus M, Linda M, Jan O, Carlo P, Petar S, Miguel S, Marja R, Michal T, Jaakko T, Paul V and Jose L (2013): Pre-diabetes, and cardio-vascular diseases developed in collaboration with the EASD. European Heart Journal, 10: 1093-1123.
14. Pahor M, Elam M, Garrison R, Kritchevsky S and Applegate W (1999): Emerging noninvasive biochemical measures to predict cardiovascular risk. Archives of Internal Medicine, 159(3): 237-245.
15. Parsa A, Ghadirian L, Kanafi S and Farsani E (2013): Positive Correlation between Microalbuminuria and Severity of Coronary Artery Stenosis in Patients with Type 2 Diabetes Mellitus. Acta Medica Iranica., 51(4): 231-235.
16. Parvizi R, Rahbani M, Salmasi S and Safavi M (2005): Relationship between Microalbumi-nuria and Extent of Coronary Atherosclerotic Lesions.Iranian Heart Journal, 6 (1, 2): 20-25.
17. Sadaka M, Elhadedy A, Abdelhalim S and Elashmawy H (2013): Albumin to creatinine ratio as a predictor to the severity of coronary artery disease.Alexandria Journal of Medicine, 49: 323–328.
18. Sigdel M, Rajbhandari N, Basnet S, Nagila A, Basnet P and Tamrakar B (2008): Microalbuminuria among type-2 diabetes mellitus patients in Pokhara, Nepal Med Coll., 10(4): 242-245.
19. Stehouwer C, Henry R, Dekker J, Nijpels G, Heine R and Bouter L (2004): Microalbuminuria is associated with impaired brachial artery, flow-mediated vasodilation in elderly individuals without and with diabetes: Further evidence for a link between microalbuminuria and endothelial dysfunction The Hoorn Study. Kidney International, 92: 42-44.
20. Sukhija R, Aronow W, Kakar P, Garza L, Sachdeva R, Sinha A and Mehta J (2006): Relation of Microalbuminuria and Coronary Artery Disease in Patients With and Without Diabetes Mellitus.Am Journal of Card., 98:3: 279–281.